Artículos de revistas sobre el tema "Vaccins ADN"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Vaccins ADN".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ladenheim, Ruth. "Les vaccins à ADN nu". Biofutur 1995, n.º 145 (mayo de 1995): 14. http://dx.doi.org/10.1016/0294-3506(95)80125-1.
Texto completoPitard, Bruno. "Nanotaxi® pour les vaccins ARN et ADN". médecine/sciences 35, n.º 10 (octubre de 2019): 749–52. http://dx.doi.org/10.1051/medsci/2019143.
Texto completoQUENTEL, C., M. BREMONT y H. POULIQUEN. "La vaccination chez les poissons d’élevage". INRAE Productions Animales 20, n.º 3 (7 de septiembre de 2007): 233–38. http://dx.doi.org/10.20870/productions-animales.2007.20.3.3463.
Texto completoParis, Robert, Robert A. Kuschner, Leonard Binn, Stephen J. Thomas, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Robert T. Bailer, Nancy Sullivan y Richard A. Koup. "Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors". Clinical and Vaccine Immunology 21, n.º 5 (12 de marzo de 2014): 783–86. http://dx.doi.org/10.1128/cvi.00011-14.
Texto completoHarro, Clayton, Xiao Sun, Jon E. Stek, Randi Y. Leavitt, Devan V. Mehrotra, Fubao Wang, Andrew J. Bett et al. "Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults". Clinical and Vaccine Immunology 16, n.º 9 (15 de julio de 2009): 1285–92. http://dx.doi.org/10.1128/cvi.00144-09.
Texto completoBeaty, Shannon, Natalie Collins, Nicos Karasavvas, Robert Kuschner, Jun Hang, Anima Adhikari, Irina Maljkovic Berry et al. "A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults". Vaccines 11, n.º 6 (12 de junio de 2023): 1091. http://dx.doi.org/10.3390/vaccines11061091.
Texto completo邱南昌, 邱南昌 y 張濱璿 Nan-Chang Chiu. "臺灣預防接種受害救濟制度與COVID-19疫苗". 月旦醫事法報告 67, n.º 67 (mayo de 2022): 050–61. http://dx.doi.org/10.53106/241553062022050067004.
Texto completoHalstead, Scott B. y Leah Katzelnick. "COVID-19 Vaccines: Should We Fear ADE?" Journal of Infectious Diseases 222, n.º 12 (12 de agosto de 2020): 1946–50. http://dx.doi.org/10.1093/infdis/jiaa518.
Texto completoYılmaz, Engin. "Aşı Teknolojisinde Yeni Umutlar: mRNA Aşıları". Mikrobiyoloji Bulteni 55, n.º 2 (19 de abril de 2021): 265–84. http://dx.doi.org/10.5578/mb.20219912.
Texto completoAppledorn, Daniel M., Yasser A. Aldhamen, Sarah Godbehere, Sergey S. Seregin y Andrea Amalfitano. "Sublingual Administration of an Adenovirus Serotype 5 (Ad5)-Based Vaccine Confirms Toll-Like Receptor Agonist Activity in the Oral Cavity and Elicits Improved Mucosal and Systemic Cell-Mediated Responses against HIV Antigens despite Preexisting Ad5 Immunity". Clinical and Vaccine Immunology 18, n.º 1 (17 de noviembre de 2010): 150–60. http://dx.doi.org/10.1128/cvi.00341-10.
Texto completoGuzmán-Martínez, Oscar, Kathia Guardado, Elsa Ladrón de Guevara, Saturnino Navarro, Crescencio Hernández, Roberto Zenteno-Cuevas y Hilda Montero. "IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population". Vaccines 9, n.º 9 (8 de septiembre de 2021): 999. http://dx.doi.org/10.3390/vaccines9090999.
Texto completoTang, Jinyi, Cong Zeng, Thomas M. Cox, Chaofan Li, Young Min Son, In Su Cheon, Supriya Behl et al. "Respiratory humoral and cellular immune responses following COVID-19 mRNA vaccination". Journal of Immunology 208, n.º 1_Supplement (1 de mayo de 2022): 65.22. http://dx.doi.org/10.4049/jimmunol.208.supp.65.22.
Texto completoThiele, Sonja, Aljona Borschewski, Judit Küchler, Marc Bieberbach, Sebastian Voigt y Bernhard Ehlers. "Molecular Analysis of Varicella Vaccines and Varicella-Zoster Virus from Vaccine-Related Skin Lesions". Clinical and Vaccine Immunology 18, n.º 7 (11 de mayo de 2011): 1058–66. http://dx.doi.org/10.1128/cvi.05021-11.
Texto completoBroderick, Michael P., Sandra Romero-Steiner, Gowrisankar Rajam, Scott E. Johnson, Andrea Milton, Ellie Kim, Lisa J. Choi et al. "Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone". Clinical and Vaccine Immunology 23, n.º 8 (8 de junio de 2016): 672–80. http://dx.doi.org/10.1128/cvi.00267-16.
Texto completoBraucher, Douglas R., Jamie N. Henningson, Crystal L. Loving, Amy L. Vincent, Eun Kim, Julia Steitz, Andrea A. Gambotto y Marcus E. Kehrli. "Intranasal Vaccination with Replication-Defective Adenovirus Type 5 Encoding Influenza Virus Hemagglutinin Elicits Protective Immunity to Homologous Challenge and Partial Protection to Heterologous Challenge in Pigs". Clinical and Vaccine Immunology 19, n.º 11 (29 de agosto de 2012): 1722–29. http://dx.doi.org/10.1128/cvi.00315-12.
Texto completoWang, Anqi. "Advantages And Disadvantages of Different COVID-19 Vaccines". Highlights in Science, Engineering and Technology 45 (18 de abril de 2023): 319–24. http://dx.doi.org/10.54097/hset.v45i.7483.
Texto completoMuñoz-Valle, José Francisco, Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Cristian Oswaldo Hernández-Ramírez, Saúl Alberto Díaz-Pérez, Christian Johana Baños-Hernández, Francisco Javier Turrubiates-Hernández, Alejandra Natali Vega-Magaña y Jorge Hernández-Bello. "Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study". Vaccines 10, n.º 3 (5 de marzo de 2022): 400. http://dx.doi.org/10.3390/vaccines10030400.
Texto completoChondronasiou, Dafni, Tracy-Jane Eisden, Anita Stam, Qiana Matthews, Mert Icyuz, Erik Hooijberg, Igor Dmitriev, David Curiel, Tanja de Gruijl y Rieneke van de Ven. "Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs". Vaccines 6, n.º 3 (18 de julio de 2018): 42. http://dx.doi.org/10.3390/vaccines6030042.
Texto completoCassier, Maurice. "Producing, Controlling, and Stabilizing Pasteur's Anthrax Vaccine: Creating a New Industry and a Health Market". Science in Context 21, n.º 2 (junio de 2008): 253–78. http://dx.doi.org/10.1017/s0269889708001713.
Texto completoSun, Haiyan, Dhiraj Acharya, Amber M. Paul, Huafang Lai, Junyun He, Fengwei Bai y Qiang Chen. "Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus". Vaccines 11, n.º 2 (17 de enero de 2023): 197. http://dx.doi.org/10.3390/vaccines11020197.
Texto completoDeng, Sheng-Qun, Xian Yang, Yong Wei, Jia-Ting Chen, Xiao-Jun Wang y Hong-Juan Peng. "A Review on Dengue Vaccine Development". Vaccines 8, n.º 1 (2 de febrero de 2020): 63. http://dx.doi.org/10.3390/vaccines8010063.
Texto completoMcFarland, Elizabeth J., Ruth A. Karron, Petronella Muresan, Coleen K. Cunningham, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva et al. "Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children". Journal of Infectious Diseases 221, n.º 12 (1 de febrero de 2020): 2050–59. http://dx.doi.org/10.1093/infdis/jiaa049.
Texto completoWilson, Nancy A., Brandon F. Keele, Jason S. Reed, Shari M. Piaskowski, Caitlin E. MacNair, Andrew J. Bett, Xiaoping Liang et al. "Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge". Journal of Virology 83, n.º 13 (29 de abril de 2009): 6508–21. http://dx.doi.org/10.1128/jvi.00272-09.
Texto completoWhelan, Allison M. "Lowering the Age of Consent: Pushing Back against the Anti-Vaccine Movement". Journal of Law, Medicine & Ethics 44, n.º 3 (2016): 462–73. http://dx.doi.org/10.1177/1073110516667942.
Texto completoAli, Muhammad Zahid, Yousra Anwar, Adil Abbas, Noor Ul Ain, Zainab Khalid, Arooj Sattar, Muhammad Usman, Arzoo Nazir y Shah Zeb. "Recent Advances in Vaccine Technology for Viral Infection Management: A Spotlight on Next-Generation Vaccines and Nucleic Acid-Based Platforms". Pakistan Journal of Medical and Health Sciences 17, n.º 5 (23 de junio de 2023): 261–66. http://dx.doi.org/10.53350/pjmhs2023175261.
Texto completoCrum, Tommie, Kirsten Mooney y Birendra R. Tiwari. "Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases". F1000Research 10 (7 de diciembre de 2021): 652. http://dx.doi.org/10.12688/f1000research.51160.2.
Texto completoCrum, Tommie, Kirsten Mooney y Birendra R. Tiwari. "Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases". F1000Research 10 (26 de julio de 2021): 652. http://dx.doi.org/10.12688/f1000research.51160.1.
Texto completoMatsegora, N. А. y A. V. Kaprosh. "Current state of developments and research of new candidate vaccines against tuberculosis (literature review)". Tuberculosis, Lung Diseases, HIV Infection, n.º 2 (17 de junio de 2022): 48–57. http://dx.doi.org/10.30978/tb-2022-2-48.
Texto completoLiang, Xiaoping, Danilo R. Casimiro, William A. Schleif, Fubao Wang, Mary-Ellen Davies, Zhi-Qiang Zhang, Tong-Ming Fu et al. "Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys". Journal of Virology 79, n.º 19 (1 de octubre de 2005): 12321–31. http://dx.doi.org/10.1128/jvi.79.19.12321-12331.2005.
Texto completoLau, Chin Shern, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu y Tar Choon Aw. "Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore". Antibodies 11, n.º 2 (27 de mayo de 2022): 38. http://dx.doi.org/10.3390/antib11020038.
Texto completoSteinhoff, Mark C., George F. Reed, Michael D. Decker, Kathryn M. Edwards, Janet A. Englund, Michael E. Pichichero, Margaret B. Rennels, Edwin L. Anderson, Maria A. Deloria y Bruce D. Meade. "A Randomized Comparison of Reactogenicity and Immunogenicity of Two Whole-Cell Pertussis Vaccines". Pediatrics 96, n.º 3 (1 de septiembre de 1995): 567–70. http://dx.doi.org/10.1542/peds.96.3.567.
Texto completoKim, Ji Yeun, So Yun Lim, Soonju Park, Ji-Soo Kwon, Seongman Bae, Ji Young Park, Hye Hee Cha et al. "Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period". Journal of Infectious Diseases 225, n.º 5 (25 de noviembre de 2021): 777–84. http://dx.doi.org/10.1093/infdis/jiab579.
Texto completoCasimiro, Danilo R., Aimin Tang, Ling Chen, Tong-Ming Fu, Robert K. Evans, Mary-Ellen Davies, Daniel C. Freed et al. "Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene". Journal of Virology 77, n.º 13 (1 de julio de 2003): 7663–68. http://dx.doi.org/10.1128/jvi.77.13.7663-7668.2003.
Texto completoIyasu Angani, Dereja. "Veterinary vaccine development: The helical project". Insights in Veterinary Science 4, n.º 1 (28 de agosto de 2020): 042–47. http://dx.doi.org/10.29328/journal.ivs.1001025.
Texto completoKang, Chang-Yuil, Soojeong Chang, Kwang-Soo Shin, In Kyung Jung, Hyemin Park, Jonghan Oh, Seowoo Park, Jieun Shin y Jong Heon Kim. "Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform." Journal of Immunology 210, n.º 1_Supplement (1 de mayo de 2023): 159.06. http://dx.doi.org/10.4049/jimmunol.210.supp.159.06.
Texto completoKawile, Leo, Keli Fisher y Mia Noergaard. "An Exploration of the Relationship Between Vaccine Knowledge and Vaccine Willingness". Psi Beta Research Journal - Brief Reports 3, n.º 1 (12 de octubre de 2023): 56–60. http://dx.doi.org/10.54581/luzr1510.
Texto completoCamacho, Luiz Antonio Bastos, Marcos da Silva Freire, Maria da Luz Fernandes Leal, Savitri Gomes de Aguiar, Jussara Pereira do Nascimento, Takumi Iguchi, José de Azevedo Lozana y Roberto Henrique Guedes Farias. "Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial". Revista de Saúde Pública 38, n.º 5 (octubre de 2004): 671–78. http://dx.doi.org/10.1590/s0034-89102004000500009.
Texto completoBalatif, Ridwan, Fadlan Hafizh Harahap y Isni Dhiyah Almira. "Recent Development on HIV Variants and HIV Vaccine". Cermin Dunia Kedokteran 49, n.º 12 (1 de diciembre de 2022): 687–92. http://dx.doi.org/10.55175/cdk.v49i12.328.
Texto completoKamboj, Sakshi, Siya Srivastava, Sana Siddiqui y Rohit Singh. "A WEB-BASED CROSS-SECTIONAL STUDY AMONG INDIANS REVEALS A WILLINGNESS SHIFT REGARDING COVID-19 VACCINE UPTAKE AFTER THE SECOND WAVE". Journal of Experimental Biology and Agricultural Sciences 9, n.º 5 (30 de octubre de 2021): 647–56. http://dx.doi.org/10.18006/2021.9(5).647.656.
Texto completoWang, Meicheng. "Dengue virus and vaccines: A review". Theoretical and Natural Science 15, n.º 1 (4 de diciembre de 2023): 292–98. http://dx.doi.org/10.54254/2753-8818/15/20240502.
Texto completoAuclair, Sarah, Lynn Soong y Haitao Hu. "Differential T follicular helper cell responses induced by candidate HIV vaccine strategies utilizing ALVAC versus Ad5 vectors". Journal of Immunology 200, n.º 1_Supplement (1 de mayo de 2018): 125.22. http://dx.doi.org/10.4049/jimmunol.200.supp.125.22.
Texto completoKotaki, Tomohiro, Yurie Nagai, Atsushi Yamanaka, Eiji Konishi y Masanori Kameoka. "Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection". Vaccines 10, n.º 9 (28 de agosto de 2022): 1411. http://dx.doi.org/10.3390/vaccines10091411.
Texto completoBarouch, Dan H., Paul F. McKay, Shawn M. Sumida, Sampa Santra, Shawn S. Jackson, Darci A. Gorgone, Michelle A. Lifton et al. "Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines". Journal of Virology 77, n.º 16 (15 de agosto de 2003): 8729–35. http://dx.doi.org/10.1128/jvi.77.16.8729-8735.2003.
Texto completoTogoo, Khongorzul, Burenjargal Batmunkh, Nomin-Erdene Tsogtbayar, Ulziisaikhan Batmunkh, Enkhtuya Selenge, Khuselt-Od Togtokhbaatar, Gantuya Boldbaatar, Davaalkham Jagdagsuren, Batbaatar Gunchin y Tsogtsaikhan Sandag. "Antibody response of Comirnaty vaccine in different immunocompromised groups during the COVID-19 pandemic". Journal of Immunology 210, n.º 1_Supplement (1 de mayo de 2023): 252.13. http://dx.doi.org/10.4049/jimmunol.210.supp.252.13.
Texto completoKrasnopolsky, Yu. "BIOTECHNOLOGICAL RESEARCH IN THE CREATION AND PRODUCTION OF ANTIRABIC VACCINES". Biotechnologia Acta 14, n.º 4 (agosto de 2021): 28–37. http://dx.doi.org/10.15407/biotech14.04.028.
Texto completoI, Rabiu. "COVID-19 Vaccine Hesitancy in Africa and Asian Continent: A Comparative Study Between Nigeria and Nepal". Vaccines & Vaccination Open Access 8, n.º 2 (4 de agosto de 2023): 1–8. http://dx.doi.org/10.23880/vvoa-16000166.
Texto completoCamara, Aichetou, Anaïs Razurel, Christelle Moreau, Thérésa Kwon, Marion Caseris, Olivier Bourdon y Sonia Prot-Labarthe. "P44 Vaccine in pediatric chronic kidney disease (CKD) and hemodialysis". Archives of Disease in Childhood 105, n.º 9 (19 de agosto de 2020): e29.2-e30. http://dx.doi.org/10.1136/archdischild-2020-nppg.53.
Texto completoTapia-Calle, Gabriela, Philip A. Born, Georgia Koutsoumpli, Martin Ignacio Gonzalez-Rodriguez, Wouter L. J. Hinrichs y Anke L. W. Huckriede. "A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro". Vaccines 7, n.º 4 (13 de noviembre de 2019): 181. http://dx.doi.org/10.3390/vaccines7040181.
Texto completoWei, Yunhua, Yan Wang, Lin Liu, Yan Zha, Yuqi Yang, Yuanlin Wang, Neil Roberts y Yaying Li. "Analysis of Adverse Effects of COVID-19 Vaccines Experienced by Healthcare Workers at Guizhou Provincial Staff Hospital, China". Vaccines 10, n.º 9 (2 de septiembre de 2022): 1449. http://dx.doi.org/10.3390/vaccines10091449.
Texto completoGbaj, Abdul. "Mixing of Sputnik V and AstraZeneca COVID-19 vaccines". Clinical Research Notes 2, n.º 1 (6 de septiembre de 2021): 01–03. http://dx.doi.org/10.31579/2690-8816/034.
Texto completo